针对神经退行性疾病的向蛋白质降解的当代趋势
Gulshan Kumar1, Vaibhav Thakur2, Satish Sardana1
1Amity Institute of Pharmacy, Amity University Haryana, 122413, India.
European journal of medicinal chemistry
|September 6, 2025
概括
有针对性的蛋白质降解 (TPD) 通过清除有害的错误折叠蛋白质,为神经退行性疾病 (NDs) 提供了新的治疗方法. 新的TPD技术,如PROTAC和LYTAC显示出在ND中药物发现的前景.
科学领域:
- 神经科学
- 分子生物学
- 药物发现
背景情况:
- 神经退行性疾病 (NDs) 涉及由于错误折叠蛋白质的积累而导致的认知和运动能力下降 (例如,粉样β,,α-synuclein).
- 传统的小分子药物很难有效地向这些致病蛋白质.
研究的目的:
- 提供新兴向蛋白质降解 (TPD) 技术的概述.
- 探索TPD在神经退行性疾病治疗中的潜在应用.
- 为了指导研究人员快速发展的TPD领域.
主要方法:
- 对蛋白解向基因组 (PROTACs) 和酶向基因组 (LYTACs) 的审查.
- 讨论新的TPD策略,包括分子接剂,基于抗体的PROTACs (AbTACs) 和AUTOphagy-TTargeting Chimeras (AUTOTACs).
- 分析TPD利用细胞破坏途径的机制.
主要成果:
- 包括PROTAC和LYTAC在内的TPD策略显示出消除与疾病相关的蛋白质的巨大潜力.
- 新兴的TPD技术正在扩大ND的治疗可能性.
- 这些方法为药物发现提供了新的途径,
结论:
- 有针对性的蛋白质降解是神经退行性疾病的有希望的治疗策略.
- 对于阿尔茨海默病,帕金森病和亨廷顿病等疾病的新疗法,
- 这篇综述为生物学家和化学家提供了TPD不断变化的指南.
相关概念视频
Regulated Protein Degradation
7.6K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.6K
The Proteasome
1.1K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.1K
Protein Networks
4.1K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K
Parkinson's Disease: Overview
702
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
702
Proteins: From Genes to Degradation
3.6K
3.6K
Amyloid Fibrils
9.8K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.8K


